11/16/2023: CDC and FDA Expedite the Availability of Additional Doses of New RSV Immunization for Infants

11/16/2023: DHS Reminds Wisconsinites to Protect Themselves as Cases of RSV and Respiratory Viruses Increase

11/6/2023: CDC Expands Testing of International Air Traveler Samples to Include Flu, RSV, and Other Respiratory Viruses

10/23/2023: Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from RSV during the 2023–2024 Respiratory Virus Season

9/22/2023: CDC Recommends New Vaccine to Help Protect Babies Against Severe RSV Illness After Birth

9/13/2023: DHS Calls on Wisconsinites to Make a Plan to Protect Against Respiratory Illnesses This Fall

9/5/2023: Increased RSV Activity in Parts of the Southeastern United States: New Prevention Tools Available to Protect Patients

8/3/2023: CDC Recommends a Powerful New Tool to Protect Infants from Leading Cause of Hospitalization

6/29/2023: CDC Recommends RSV Vaccine for Older Adults

Revised 11.17.2023